NAOV logo

NanoVibronix, Inc. Common Stock


NAOV: NanoVibronix Inc manufactures noninvasive biological response-activating devices that target biofilm prevention, pain therapy, and wound healing and can be administered at home, without the assistance of medical professionals. Its primary products are UroShield; PainShield; and WoundShield. Each of its UroShield, PainShield, and WoundShield products employs a small, disposable transducer that transmits low frequency, low intensity ultrasound acoustic waves that seek to repair and regenerate tissue, musculoskeletal and vascular structures, and decrease biofilm formation on urinary catheters and associated urinary tract infections. The company derives revenues from selling its products directly to patients as well as through distributor agreements.


Show NAOV Financials

Consumer Interest
SEC Filings

Recent trades of NAOV by members of U.S. Congress

Quiver Logo

No Congress Trading data for this ticker

Congress Trading Dashboard

Recently reported changes by institutional investors

Quarterly net insider trading by NAOV's directors and management

Government lobbying spending instances

  • $5,000 Jul 14, 2021 Issue: Health Issues
  • $15,000 Apr 22, 2021 Issue: Health Issues
  • $30,000 Jan 11, 2021 Issue: Health Issues
U.S. Patents

New patents grants

  • Patent Title: System and method for surface acoustic wave treatment of skin Mar. 07, 2017
  • Patent Title: System and method for surface acoustic wave treatment of medical devices May. 12, 2015
Government Contracts

Federal grants, loans, and purchases

Quiver Logo

No Government Contracts for this ticker

Government Contracts Dashboard

Number of mentions of NAOV in WallStreetBets Daily Discussion


Recent insights relating to NAOV

CNBC Recommendations

Recent picks made for NAOV stock on CNBC

Top ETF Holders

ETFs with the largest estimated holdings in NAOV

Corporate Flights

Flights by private jets registered to NAOV